Collagen Matrix Names Tim Starr Chief Operating Officer

Collagen Matrix Names Tony Orsini Chief Operating Officer We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen Matrix, Inc. Tim is a Biochemist with more than 30 years of leadership experience in life sciences manufacturing and supply chain. Most recently he was Vice President of Operations for Boston…

Read More

Collagen Matrix Acquires Polyganics

Collagen Matrix Acquires Polyganics

The Investment Expands CMI’s Regenerative Medicine Portfolio, R&D Capabilities and International Manufacturing Operations Oakland, N.J., October 5, 2022 – Collagen Matrix, Inc. (“Collagen Matrix”), a global leader in regenerative medicine and a Linden Capital Partners (“Linden”) portfolio company, today announced the acquisition of Polyganics, B.V (“Polyganics”).  Polyganics is a medical technology company that develops and…

Read More

Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market

Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance…

Read More

Collagen Matrix Names Timothy J. Scannell to its Board of Directors

Collagen Matrix Names Timothy J. Scannell to its Board of Directors Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Timothy J. Scannell to its board of directors. A seasoned and dynamic medical device leader, Mr. Scannell…

Read More

Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business

Collagen Matrix Acquires Sunstar’s GUIDOR® Synthetic Bone Graft & Membrane Business Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and portfolio company of Linden Capital Partners (“Linden”), announced today the acquisition of Sunstar’s Degradable Solutions division (the “Company”), including its GUIDOR® branded line of resorbable synthetic medical implants. Founded in 1999, Degradable…

Read More

Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix

Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine…

Read More

Collagen Matrix Launches OssiMend® Spine and DuraMatrix® Dural Repair Products in Asia

Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today its first entrance into the India market with two product lines, OssiMend® bone graft matrices from its Spine Business Unit and DuraMatrix®membranes from its Dural Repair Business Unit. Collagen Matrix Launches OssiMend® Spine and…

Read More

Collagen Matrix Celebrates 20 Years of Science, Technology and Innovation

Collagen Matrix Celebrates 20 Years of Science, Technology and Innovation It started with an idea that transformed into a success story, 20 years in the making. Today, Collagen Matrix, celebrating its 20th anniversary, has developed collagen and mineral based medical devices that have helped patients worldwide with over 7.5 million products sold. The Company has…

Read More

Shu-Tung Li to be Inducted Into The AIMBE College of Fellows

Shu-Tung Li to be Inducted Into The AIMBE College of Fellows Collagen Matrix, Inc., the driving force in the design, development and manufacturing of collagen and mineral based medical devices for tissue repair and regeneration announced today that Shu-Tung Li, Ph.D., Founder and Chief Scientific Officer of the Company will be inducted by The American…

Read More

Collagen Matrix, Inc. Selected to Participate in FDA’s Experiential Learning Program

Collagen Matrix, Inc. Selected to Participate in FDA’s Experiential Learning Program Collagen Matrix, Inc., a leading provider of high quality products and technology used in tissue repair and regeneration announced today it has been selected to participate in the Food and Drug Administration’s Experiential Learning Program (ELP).  The ELP is designed to provide the FDA’s…

Read More